<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font26 { font-size : 26; } .font28 { font-size : 28; } .font29 { font-size : 29; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">HBV </span>
   <span class="font29">hepatitis </span>
   <span class="font28">transmission </span>
   <span class="font26">pregnancy </span>
   <span class="font25">meta-analysis </span>
   <span class="font24">trimester </span>
   <span class="font23">MTCT </span>
   <span class="font22">network </span>
   <span class="font20">antiviral </span>
   <span class="font20">pregnant </span>
   <span class="font20">treatment </span>
   <span class="font20">safety </span>
   <span class="font19">efficacy </span>
   <span class="font19">non-RCTs </span>
   <span class="font18">{border-style </span>
   <span class="font17">high </span>
   <span class="font17">late </span>
   <span class="font17">preventing </span>
   <span class="font17">px;} </span>
   <span class="font17">#ffffff;} </span>
   <span class="font17">AVT </span>
   <span class="font17">agents </span>
   <span class="font17">different </span>
   <span class="font17">telbivudine </span>
   <span class="font16">maternal </span>
   <span class="font16">virus </span>
   <span class="font16">control </span>
   <span class="font16">data </span>
   <span class="font16">prevent </span>
   <span class="font16">risk </span>
   <span class="font16">second </span>
   <span class="font16">timing </span>
   <span class="font16">Fig. </span>
   <span class="font16">RCTs </span>
   <span class="font16">analysis </span>
   <span class="font16">studies </span>
   <span class="font16">therapy </span>
   <span class="font16">viral </span>
   <span class="font15">chronic </span>
   <span class="font15">(Fig. </span>
   <span class="font15">DNA </span>
   <span class="font15">HBeAg </span>
   <span class="font15">non-RCTs: </span>
   <span class="font15">versus </span>
   <span class="font15">vertical </span>
   <span class="font14">compared </span>
   <span class="font14">Hepatol </span>
   <span class="font14">Viral </span>
   <span class="font14">[]. </span>
   <span class="font14">level </span>
   <span class="font14">mother-to-child </span>
   <span class="font14">mothers </span>
   <span class="font14">perinatal </span>
   <span class="font14">significant </span>
   <span class="font13">Gastroenterol </span>
   <span class="font13">Hepat </span>
   <span class="font13">al.Efficacy </span>
   <span class="font13">female </span>
   <span class="font13">mother-to-infant </span>
   <span class="font13">provided </span>
   <span class="font13">trimester, </span>
   <span class="font13">trimesters </span>
   <span class="font13">week </span>
   <span class="font13">women </span>
   <span class="font13">MTCT. </span>
   <span class="font13">bias </span>
   <span class="font13">conducted </span>
   <span class="font13">effect </span>
   <span class="font13">infant </span>
   <span class="font13">low </span>
   <span class="font13">outcomes </span>
   <span class="font13">px; </span>
   <span class="font13">reducing </span>
   <span class="font13">use </span>
   <span class="font13">{font-family </span>
   <span class="font13">agent </span>
   <span class="font13">evidence </span>
   <span class="font13">font-size </span>
   <span class="font13">patients </span>
   <span class="font13">prior </span>
   <span class="font13">showed </span>
   <span class="font13">started </span>
   <span class="font13">study </span>
   <span class="font13">tenofovir </span>
   <span class="font12">However, </span>
   <span class="font12">addition, </span>
   <span class="font12">double; </span>
   <span class="font12">early </span>
   <span class="font12">early-middle </span>
   <span class="font12">included </span>
   <span class="font12">indicated </span>
   <span class="font12">middle </span>
   <span class="font12">months </span>
   <span class="font12">obtain </span>
   <span class="font12">plot </span>
   <span class="font12">positive </span>
   <span class="font12">pregnancy. </span>
   <span class="font12">starting </span>
   <span class="font12">studies. </span>
   <span class="font12">untreated </span>
   <span class="font12">ALT </span>
   <span class="font12">Forest </span>
   <span class="font12">HBV. </span>
   <span class="font12">LDT </span>
   <span class="font12">S). </span>
   <span class="font12">based </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">completely </span>
   <span class="font12">controlled </span>
   <span class="font12">delivery </span>
   <span class="font12">earlier </span>
   <span class="font12">effective </span>
   <span class="font12">first, </span>
   <span class="font12">gestation </span>
   <span class="font12">group, </span>
   <span class="font12">initiated </span>
   <span class="font12">initiation </span>
   <span class="font12">interrupting </span>
   <span class="font12">pair-wised </span>
   <span class="font12">pooled </span>
   <span class="font12">prevention </span>
   <span class="font12">prospective </span>
   <span class="font12">rate </span>
   <span class="font12">received </span>
   <span class="font12">similar </span>
   <span class="font12">solid; </span>
   <span class="font12">studies, </span>
   <span class="font12">systematic </span>
   <span class="font12">used </span>
   <span class="font12">weeks </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">.Eâˆ’ </span>
   <span class="font11">Bayesian </span>
   <span class="font11">Commons </span>
   <span class="font11">Creative </span>
   <span class="font11">Efficacy </span>
   <span class="font11">Funding </span>
   <span class="font11">JL, </span>
   <span class="font11">Major </span>
   <span class="font11">National </span>
   <span class="font11">Network </span>
   <span class="font11">Science </span>
   <span class="font11">TC. </span>
   <span class="font11">TDF </span>
   <span class="font11">Therefore, </span>
   <span class="font11">YW, </span>
   <span class="font11">[], </span>
   <span class="font11">administration </span>
   <span class="font11">al.Clinical </span>
   <span class="font11">appeared </span>
   <span class="font11">article </span>
   <span class="font11">associated </span>
   <span class="font11">better </span>
   <span class="font11">blocking </span>
   <span class="font11">bold </span>
   <span class="font11">comparing </span>
   <span class="font11">comparisons </span>
   <span class="font11">courier; </span>
   <span class="font11">decreasing </span>
   <span class="font11">disoproxil </span>
   <span class="font11">em; </span>
   <span class="font11">fumarate </span>
   <span class="font11">improvement </span>
   <span class="font11">infants </span>
   <span class="font11">infection </span>
   <span class="font11">initiating </span>
   <span class="font11">load </span>
   <span class="font11">material </span>
   <span class="font11">nonrandomized </span>
   <span class="font11">outcomes: </span>
   <span class="font11">performed </span>
   <span class="font11">positivity </span>
   <span class="font11">pregnancy: </span>
   <span class="font11">pt;} </span>
   <span class="font11">quality </span>
   <span class="font11">rare </span>
   <span class="font11">recommended </span>
   <span class="font11">reduce </span>
   <span class="font11">respectively </span>
   <span class="font11">review </span>
   <span class="font11">selection </span>
   <span class="font11">statistically </span>
   <span class="font11">superior </span>
   <span class="font11">supplementary </span>
  </p>
 </body>
</html>
